Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis

NMR in Biomedicine

Volumn 21, Issue 6, 2008, Pages 589-597

  Budde, Matthew D ^a   Kim, Joong Hee ^a   Liang, Hsiao Fang ^a   Russell, John H ^b   Cross, Anne H ^b   Song, Sheng Kwei ^a,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Axial diffusivity; Axonal damage; Demyelination; Diffusion tensor imaging; Experimental autoimmune encephalomyelitis; Radial diffusivity; Spinal cord; White matter

Indexed keywords

CRYSTALLOGRAPHY; DIFFUSION; HEALTH; PAINTING; SEMICONDUCTOR DOPING;

ANIMAL MODELS; AXIAL DIFFUSIVITY; AXONAL DAMAGE; DEMYELINATION; DIFFUSION TENSOR IMAGING; DIFFUSIVITIES; DIFFUSIVITY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IN-VIVO; MOUSE MODELS; MULTIPLE SCLEROSIS; NEGATIVE CORRELATIONS; NEUROFILAMENTS; NON-INVASIVE; RADIAL DIFFUSIVITY; RELATIVE ANISOTROPY; SPINAL CORD; SPINAL CORDS; SURROGATE MARKERS; WHITE MATTER;

TENSORS;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANISOTROPY; ARTICLE; AXONAL INJURY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSION TENSOR IMAGING; DISEASE MARKER; DISEASE SEVERITY; FEMALE; IMAGE ANALYSIS; IN VIVO STUDY; MALE; MOUSE; MULTIPLE SCLEROSIS; NEUROFILAMENT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RISK FACTOR; SCORING SYSTEM; SIGNAL DETECTION; WHITE MATTER;

ANIMALS; DEMYELINATING DISEASES; DIFFUSE AXONAL INJURY; DIFFUSION MAGNETIC RESONANCE IMAGING; DISEASE MODELS, ANIMAL; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; NERVOUS SYSTEM DISEASES; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPINAL CORD; STATISTICS AS TOPIC;

ANIMALIA; MUS;

EID: 48349129527     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1229     Document Type: Article

References (34)

1. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001; 50(1): 121-127.
2. Barkhof F. The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol. 2002; 15(3): 239-245.
3. Barkhof F. MRI in multiple sclerosis: correlation with expanded disability status scale (EDSS). Mult Scler. 1999; 5(4): 283-286.
4. McFarland HF, Barkhof F, Antel J, Miller DH. The role of MRI as a surrogate outcome measure in multiple sclerosis. Mult Scler. 2002; 8(1): 40-51.
5. Schwartz ED, Chin CL, Shumsky JS, Jawad AF, Brown BK, Wehrli S, Tessler A, Murray M, Hackney DB. Apparent diffusion coefficients in spinal cord transplants and surrounding white matter correlate with degree of axonal dieback after injury in rats. AJNR Am J Neuroradiol. 2005; 26(1): 7-18.
6. Schwartz ED, Cooper ET, Fan Y, Jawad AF, Chin CL, Nissanov J, Hackney DB. MRI diffusion coefficients in spinal cord correlate with axon morphometry. Neuroreport 2005; 16(1): 73-76.
7. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH. Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 2002; 17(3): 1429-1436.
8. Sun SW, Liang HF, Trinkaus K, Cross AH, Armstrong RC, Song SK. Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn Reson Med. 2006; 55(2): 302-308.
9. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH. Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 2003; 20(3): 1714-1722.
10. Sabelko-Downes KA, Cross AH, Russell JH. Dual role for Fas ligand in the initiation of and recovery from experimental allergic encephalomyelitis. J Exp Med. 1999; 189(8): 1195-1205.
11. Okuda Y, Okuda M, Bernard CC. Gender does not influence the susceptibility of C57BL/6 mice to develop chronic experimental autoimmune encephalomyelitis induced by myelin oligodendrocyte glycoprotein. Immunol Lett. 2002; 81(1): 25-29.
12. Cross AH, Misko TP, Lin RF, Hickey WF, Trotter JL, Tilton RG. Aminoguanidine, an inhibitor of inducible nitric oxide synthase, ameliorates experimental autoimmune encephalomyelitis in SJL mice. J Clin Invest. 1994; 93(6): 2684-2690.
13. Kim JH, Budde MD, Liang HF, Klein RS, Russell JH, Cross AH, Song SK. Detecting axon damage in spinal cord from a mouse model of multiple sclerosis. Neurobiol Dis. 2006; 21(3): 626-632.
14. Stejskal EO, Tanner JE. Spin diffusion measurements: spin echoes in the presence of a time-dependent field gradient. J Chem Phys. 1965; 42(1): 288-292.
15. Rasband WS. ImageJ. U.S. National Institutes of Health: Bethesda, MD, 1997-2005.
16. Wheeler-Kingshott CA, Hickman SJ, Parker GJ, Ciccarelli O, Symms MR, Miller DH, Barker GJ. Investigating cervical spinal cord structure using axial diffusion tensor imaging. Neuroimage 2002; 16(1): 93-102.
17. Nair G, Tanahashi Y, Low HP, Billings-Gagliardi S, Schwartz WJ, Duong TQ. Myelination and long diffusion times alter diffusion-tensor-imaging contrast in myelin-deficient shiverer mice. Neuroimage 2005; 28(1): 165-174.
18. Budde MD, Kim JH, Liang HF, Schmidt RE, Russell JH, Cross AH, Song SK. Toward accurate diagnosis of white matter pathology using diffusion tensor imaging. Magn Reson Med. 2007; 57(4): 688-695.
19. Rao P, Segal BM. Experimental autoimmune encephalomyelitis. Methods Mol Med. 2004; 102: 363-375.
20. Wujek JR, Bjartmar C, Richer E, Ransohoff RM, Yu M, Tuohy VK, Trapp BD. Axon loss in the spinal cord determines permanent neurological disability in an animal model of multiple sclerosis. J Neuropathol Exp Neurol. 2002; 61(1): 23-32.
21. Papadopoulos D, Pham-Dinh D, Reynolds R. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat. Exp Neurol. 2006; 197(2): 373-385.
22. Kalkers NF, Bergers E, Castelijns JA, van Walderveen MA, Bot JC, Ader HJ, Polman CH, Barkhof F. Optimizing the association between disability and biological markers in MS. Neurology 2001; 57(7): 1253-1258.
23. Benedict RH, Weinstock-Guttman B, Fishman I, Sharma J, Tjoa CW, Bakshi R. Prediction of neuropsychological impairment in multiple sclerosis: comparison of conventional magnetic resonance imaging measures of atrophy and lesion burden. Arch Neurol. 2004; 61(2): 226-230.
24. 2 hypointensity of the dentate nucleus is related to ambulatory impairment in multiple sclerosis. J Neurol Sci. 2005; 234(1-2): 17-24.
25. Charil A, Zijdenbos AP, Taylor J, Boelman C, Worsley KJ, Evans AC, Dagher A. Statistical mapping analysis of lesion location and neurological disability in multiple sclerosis: application to 452 patient data sets. Neuroimage 2003; 19(3): 532-544.
26. Sinnige LG, Teeuwissen E, Hew JM, Minderhoud JM. Correlation between magnetic resonance imaging and clinical parameters in multiple sclerosis. Acta Neurol Scand. 1995; 91(3): 188-191.
27. Santos AC, Narayanan S, de Stefano N, Tartaglia MC, Francis SJ, Arnaoutelis R, Caramanos Z, Antel JP, Pike GB, Arnold DL. Magnetization transfer can predict clinical evolution in patients with multiple sclerosis. J Neurol. 2002; 249(6): 662-668.
28. Mainero C, De Stefano N, Iannucci G, Sormani MP, Guidi L, Federico A, Bartolozzi ML, Comi G, Filippi M. Correlates of MS disability assessed in vivo using aggregates of MR quantities. Neurology 2001; 56(10): 1331-1334.
29. Narayana PA, Wolinsky JS, Rao SB, He R, Mehta M. Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis. Mult Scler. 2004; 10 (Suppl 1): S73-78.
30. 2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol. 2002; 23(3): 371-375.
31. De Stefano N, Narayanan S, Francis GS, Arnaoutelis R, Tartaglia MC, Antel JP, Matthews PM, Arnold DL. Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol. 2001; 58(1): 65-70.
32. Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S. Axonal changes in chronic demyelinated cervical spinal cord plaques. Brain 2000; 123(Pt 2): 308-317.
33. Losseff NA, Webb SL, O'Riordan JI, Page R, Wang L, Barker GJ, Tofts PS, McDonald WI, Miller DH, Thompson AJ. Spinal cord atrophy and disability in multiple sclerosis. A new reproducible and sensitive MRI method with potential to monitor disease progression. Brain 1996; 119(Pt 3): 701-708.
34. Stevenson VL, Leary SM, Losseff NA, Parker GJ, Barker GJ, Husmani Y, Miller DH, Thompson AJ. Spinal cord atrophy and disability in MS: a longitudinal study. Neurology 1998; 51(1): 234-238.